Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-09-000596
Filing Date
2009-07-23
Accepted
2009-07-23 17:34:55
Documents
1
Period of Report
2009-07-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7265
  Complete submission text file 0000914190-09-000596.txt   9131
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERUS CORP 2411 STENWELL DRIVE CONCORD CA 94520
Business Address
SCHAFER GREGORY W (Reporting) CIK: 0001193195 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 09960155